These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17146166)

  • 21. A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.
    Hayashi H; Kimura M; Yoshimoto N; Tsuzuki M; Tsunoda N; Fujita T; Yamashita T; Iwata H
    Breast Cancer; 2009; 16(2):136-40. PubMed ID: 18548321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications.
    Nash JW; Barrett TL; Kies M; Ross MI; Sneige N; Diwan AH; Lazar AJ
    J Cutan Pathol; 2007 Jan; 34(1):49-54. PubMed ID: 17214855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of recurrent breast cancer with lung metastasis resection showing four disease-free years under trastuzumab treatment].
    Hanada N; Tomiyama N; Hori K; Kusano S; Yoshida Y; Kawata K; Uchino R; Sakashita N
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2905-7. PubMed ID: 21160267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.
    McKeage K; Perry CM
    Drugs; 2002; 62(1):209-43. PubMed ID: 11790161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].
    Rai Y; Takahama T; Sagara Y; Sagara Y; Matsuyama Y; Ando M; Sagara Y; Ooi Y
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1297-300. PubMed ID: 16969028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of HER2/neu gene amplification and its protein overexpression between primary breast cancer and metastatic lymph nodes.
    Aoyama K; Kamio T; Nishikawa T; Kameoka S
    Jpn J Clin Oncol; 2010 Jul; 40(7):613-9. PubMed ID: 20202990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trastuzumab plus estrogen suppression as salvage treatment in a case of liver failure due to metastatic breast cancer.
    Martoni AA; Bernardi A; Quercia S
    Anticancer Res; 2006; 26(5B):3739-44. PubMed ID: 17094394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer.
    Wu JM; Halushka MK; Argani P
    Hum Pathol; 2010 Jun; 41(6):914-7. PubMed ID: 20338615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone receptor status does not affect the clinical benefit of trastuzumab therapy for patients with metastatic breast cancer.
    Brufsky A; Lembersky B; Schiffman K; Lieberman G; Paton VE
    Clin Breast Cancer; 2005 Aug; 6(3):247-52. PubMed ID: 16137436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indications for treatment in invasive ductal carcinoma of the breast with Herceptin from the aspect of laboratory diagnosis--study of the ERBB-2 protein and determination of the number of copies of the ERBB2 gene. Review].
    Mrhalová M; Kodet R
    Cesk Patol; 2002; 38 Suppl 1():4-14. PubMed ID: 12677891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.
    Arpino G; Gutierrez C; Weiss H; Rimawi M; Massarweh S; Bharwani L; De Placido S; Osborne CK; Schiff R
    J Natl Cancer Inst; 2007 May; 99(9):694-705. PubMed ID: 17470737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
    Asakura H; Takashima H; Mitani M; Haba R; Seo R; Yokoe K; Toyama Y; Ohkawa M
    Int J Clin Oncol; 2005 Aug; 10(4):285-8. PubMed ID: 16136377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer: complete response with the combination of sunitinib and trastuzumab in a patient with grade III ductal carcinoma.
    Puente J; Manzano A; Martin M; López-Tarruella S; Díaz-Rubio E
    Anticancer Drugs; 2010 Jan; 21 Suppl 1():S19-22. PubMed ID: 20110783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
    Glück S; Castrellon A
    Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer.
    Hortobagyi GN
    Semin Oncol; 2001 Dec; 28(6 Suppl 18):43-7. PubMed ID: 11774205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
    Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
    Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):115-8. PubMed ID: 20087043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
    Yoshida T; Horiguchi J; Koibuchi Y; Kanoh T; Iijima K; Yoshida M; Kikuchi M; Takata D; Oyama T; Iino Y; Morishita Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):907-10. PubMed ID: 15222110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare case of isolated adrenal metastasis of invasive ductal breast carcinoma.
    Andjelić-Dekić N; Božović-Spasojević I; Milošević S; Matijašević M; Karadžić K
    Srp Arh Celok Lek; 2014; 142(9-10):597-601. PubMed ID: 25518541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.